Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation

Nardilysin通过HDAC1/p53依赖的转录调控控制肠道肿瘤的发生。

阅读:5
作者:Keitaro Kanda ,Jiro Sakamoto ,Yoshihide Matsumoto ,Kozo Ikuta ,Norihiro Goto ,Yusuke Morita ,Mikiko Ohno ,Kiyoto Nishi ,Koji Eto ,Yuto Kimura ,Yuki Nakanishi ,Kanako Ikegami ,Takaaki Yoshikawa ,Akihisa Fukuda ,Kenji Kawada ,Yoshiharu Sakai ,Akihiro Ito ,Minoru Yoshida ,Takeshi Kimura ,Tsutomu Chiba ,Eiichiro Nishi ,Hiroshi Seno

Abstract

Colon cancer is a complex disease affected by a combination of genetic and epigenetic factors. Here we demonstrate that nardilysin (N-arginine dibasic convertase; NRDC), a metalloendopeptidase of the M16 family, regulates intestinal tumorigenesis via its nuclear functions. NRDC is highly expressed in human colorectal cancers. Deletion of the Nrdc gene in ApcMin mice crucially suppressed intestinal tumor development. In ApcMin mice, epithelial cell-specific deletion of Nrdc recapitulated the tumor suppression observed in Nrdc-null mice. Moreover, epithelial cell-specific overexpression of Nrdc significantly enhanced tumor formation in ApcMin mice. Notably, epithelial NRDC controlled cell apoptosis in a gene dosage-dependent manner. In human colon cancer cells, nuclear NRDC directly associated with HDAC1, and controlled both acetylation and stabilization of p53, with alterations of p53 target apoptotic factors. These findings demonstrate that NRDC is critically involved in intestinal tumorigenesis through its epigenetic regulatory function, and targeting NRDC may lead to a novel prevention or therapeutic strategy against colon cancer.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。